Skip to main content
. 2026 Sep 19;18(9):1183. doi: 10.3390/pharmaceutics18091183
BV Bacterial vaginosis
FIH First-in-human
IVPT In vitro permeation testing
PK Pharmacokinetic study
LLOQ Lower limit of quantification
HPLC-MS/MS Dual tandem high-performance liquid chromatography and mass spectrometry